Choose a section
Midwestern supermarket chain Hy-Vee is expanding its use of a mapping platform made by geographic information systems firm Esri to aid its real estate decision-making, Esri said Wednesday.
Drug maker Merck is seeking regulatory approval for an experimental tablet placed under the tongue that could be used to treat ragweed allergies.
Drug maker Bristol-Myers Squibb foresees significant effects on its business from the Patient Protection and Affordable Care Act, company executives told attendees of its recent shareholder meeting.
Japanese drug maker Takeda Pharmaceutical Co. will buy Fort Collins, Colo.-based vaccine maker Inviragen for up to $250 million, the two companies said Wednesday.
A campaign run by Midwestern mass-merchandise chain Meijer to raise money for food banks has netted more than half a million dollars, the company said.
A pharmacist in Queens has received accolades for giving out vitamins to children whose families can't afford them.
New York state's second-largest city has become the first market in which a majority of Rite Aid's stores have been converted to the Wellness format, the retail pharmacy chain said Wednesday.
The outline of an exam that will be used to certify pharmacists working in the specialty channel has received approval from the Specialty Pharmacy Certification Board, the group said.
Grand Central Terminal in New York played host to a life-sized "dollhouse" this week as Target showcased its new collection of products, including housewares, indoor and outdoor furniture and decorative items.
The global market for biosimilars will be worth nearly $2.5 billion this year, according to a new study.